Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10851-10863
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10851
Figure 1
Figure 1 Serum biomarkers of disease activity may measure inflammation, apoptosis, oxidative stress or fibrosis. This is a schematic representation of the pathophysiological processes in nonalcoholic fatty liver disease (NAFLD), markers of which may be demonstrable in serum. LDL: Low density lipoprotein; IL: Interleukin; TBARS: Thiobarbituric acid reactive substances; TIMP1: Tissue inhibitor of MMP 1.